Cri du chat (CdC) syndrome is a rare genetic disorder caused by a partial deletion of the short arm of chromosome 5. This disorder is named after the characteristic cat-like cry of affected infants. CdC syndrome is a complex disorder with a wide range of physical, cognitive, and behavioral problems. It is estimated to occur in 1 in 50,000 live births worldwide. Although CdC syndrome can be difficult to diagnose, early diagnosis and intervention can help improve the quality of life of individuals with this disorder. This article provides an overview of CdC syndrome, including its causes, symptoms, diagnosis, and management. It also offers guidance to parents on how to best support their child with CdC syndrome.
Cri du chat syndrome is caused by a partial deletion of the short arm of chromosome 5. This deletion occurs randomly during the formation of reproductive cells or during early fetal development. The severity of the deletion determines the severity of the symptoms. In some cases, the deletion is so small that it does not cause any symptoms. The exact cause of the deletion is unknown. However, it is thought to be due to a combination of genetic and environmental factors. For example, some studies have suggested that certain medications taken during pregnancy may increase the risk of CdC syndrome.
The symptoms of CdC syndrome vary depending on the severity of the deletion. Common symptoms include a high-pitched cry that resembles that of a cat, low birth weight, developmental delays, and distinctive facial features. Other symptoms may include microcephaly (small head size), heart defects, hearing loss, vision problems, and feeding difficulties.
CdC syndrome is usually diagnosed through a combination of physical examination, family history, and genetic testing. A physical exam may reveal the characteristic facial features and other physical abnormalities associated with CdC syndrome. A detailed family history may help identify other family members with similar features. Genetic testing is the most reliable method for diagnosing CdC syndrome. It involves analyzing a sample of the patient’s DNA to look for the deletion on chromosome 5. If the deletion is found, a diagnosis of CdC syndrome can be made.
The management of CdC syndrome is aimed at helping the individual reach their full potential. Treatment typically involves a multidisciplinary team of healthcare professionals, including doctors, nurses, psychologists, and occupational therapists. Treatment may include physical, occupational, and speech therapy, medications to control seizures and other symptoms, and psychological support.
Caring for a child with CdC syndrome can be challenging. Parents should be aware that their child may have significant physical, cognitive, and behavioral difficulties. It is important to provide a supportive environment and to understand the individual needs of the child. Parents can also seek out support from other families who have a child with CdC syndrome. Support groups can provide a valuable source of information and emotional support.
Cri du chat syndrome is a rare genetic disorder that can cause a wide range of physical, cognitive, and behavioral difficulties. Early diagnosis and intervention can help improve the quality of life of individuals with this disorder. Parents of children with CdC syndrome should be aware of the challenges they may face and seek out support from other families and healthcare professionals. With the right support, children with CdC syndrome can reach their full potential.
1.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
2.
The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.
3.
Research identifies nearly 200 potential breast carcinogens in food packaging materials
4.
Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.
5.
Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma
1.
CAR T + Ibrutinib in R/R Mantle Cell Lymphoma: Phase 2 TARMAC Study Insights
2.
Uncovering the Hidden Symptoms of Parathyroid Cancer in Women
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
The Basics of Langerhans Cell Histiocytosis: Understanding a Rare Disease
5.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Understanding the causes of anemia in adults beyond nutritional deficiencies
2.
An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.
3.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
4.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation